1–6 of 6 results for Intravitreal Methotrexate
Expert Panel: PVR
Christina Y Weng, MD, MBA, FASRS
Lejla Vajzovic, MD, FASRS
Isabela Martins Melo, MD
Sarah Syeda, MD
Prashant Keshao Bawankule, M.S.
Leo A. Kim, MD, PhD
Annual Meeting Talks
2024
Intravitreal Methotrexate Reduces Reoperation Rate and Improves Vision After Vitrectomy for Retinal Detachment, Trauma, and Proliferative Diabetic Retinopathy
Alan J. Franklin, MD, PhD
2022
Postoperative Intravitreal Methotrexate Injections Reduce Reoperations in Eyes With Proliferative Vitreoretinopathy and Diabetic Retinopathy
2021
Outcomes of Intravitreal Methotrexate for Proliferative Vitreoretinopathy in the Perioperative Period of Retinal Detachment Repair
Michelle Abou-Jaoude, MD
Management of Proliferative Vitreoretinopathy With Intravitreal Methotrexate Using a Treat-and-Extend Protocol
Scott D Walter, MD, MSc, FASRS
2020
Management of Proliferative Vitreoretinopathy with Intravitreal Methotrexate Using a Treat-and-Extend Protocol
Updates from the Field